Table 3.
Twelve-month recurrence among patients receiving medical care adherence to performance measurements vs. routine care.
| Endpoints | Non-exposed cohort | Fetal-exposed cohort | Early-childhood exposed cohort | Mid-childhood exposed cohort | Late-childhood exposed cohort |
|---|---|---|---|---|---|
| Recurrence (%) at 12 months | |||||
| Pa | 0.49 | 0.59 | 0.71 | 0.81 | |
| Hazard ratio (95% CI)a | Ref | 1.36 (0.57-3.23) | 1.51 (0.34-6.72) | 1.46 (0.21-10.21) | 1.35 (0.12-15.08) |
| Pb | 0.48 | 0.46 | 0.30 | 0.65 | |
| Hazard ratio (95% CI)b | Ref | 1.37 (0.57-3.27) | 1.75 (0.39-7.77) | 1.72 (0.25-12.05) | 0.65 (0.15-18.36) |
a
Evaluating the overall risk of four exposed groups compared to non-exposed group after adjusted for age, sex.
b
Evaluating the risk of four exposed groups with non-exposed group after adjusted for age, sex, history of ischemic stroke, myocardial infarction, atrial fibrillation, hypertension, diabetes, dyslipidemia, National Institute of Stroke Scale at admission, modified Rankin Scale before the index stroke and optimal adherence to key performance index.